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The functions of macrophages in healthy tissues extend beyond their well-established 
roles as immune sentinels and effectors. Among tissues, cells of the brain and heart 
possess unique excitatory properties that likely demand special support. Accordingly, 
existing evidence demonstrates that microglia in the brain has an active role in synaptic 
organization, control of neuronal excitability, phagocytic removal of debris and trophic 
support during brain development. In the heart, recent studies suggest that cardiac 
macrophages are involved in the regulation of heart homeostasis by phagocytosis, 
production of trophic and immune-related factors, and by forming direct contacts with 
cardiomyocytes to regulate electrical conduction. In this review, we discuss mechanisms 
associated with the high degree of specialization of resident macrophages in both tissues, 
their origin and heterogeneity, and their contributions in regulating homeostasis under 





Most mammalian systems and tissues contain a complex network of cells endowed with 
specialized roles that work together during the organism’s lifetime to ensure its correct 
functioning. In order to optimise their performance during this long-lasting relationship, 
some tissues such as the hematopoietic compartment in the bone marrow and the 
intestinal epithelium continuously self-renew through the action of dedicated stem cell 
lineages. Other tissues, such as the liver, are normally quiescent in the adult but can 
robustly activate after injury to replenish lost cells. A third group of tissues that includes 
the heart and the brain, do not regenerate well after injury leading to scaring rather than 
true tissue regeneration. In addition, these two tissues contain highly differentiated 
excitatory cells (cardiomyocytes and neurons) that do not re-enter the cell cycle in adult 
animals [1]. Both neurons and cardiomyocytes form excitatory networks with important 
anatomical constrains: in the case of the heart, organization of cardiomyocyte into 
packed functional networks ensures rhythmic contraction and the adequate propagation 
of electrical impulses along conduction pathways to pump blood. In the brain, axonal 
projections from different neuronal subtypes propagate electrical impulses to specific 
anatomical locations, which allows transmission and integration of signals received from 
the environment. It is therefore likely that neurons and cardiomyocytes require special 
support from other tissue-resident cells. Among these resident cells, heterogeneous 
populations of macrophages have emerged as a versatile toolkit that accomplishes 
multiple tasks in virtually every tissue [2], and these macrophages have been shown to 
be necessary for normal tissue function.  
 
Tissue-resident macrophages colonize the brain and the heart early in development and 
accumulating evidence indicates that their activity extends beyond their well-
established roles as immune sentinels and effector cells. For example, microglia has an 
active role in synaptic organization [3, 4], control of neuronal excitability [5], phagocytic 
debris removal [6], and trophic support for brain protection and repair [7]. In the case of 
the heart, functional data examining the role of cardiac tissue macrophages (cTM) in 
adult heart homeostasis is still limited; however, gene expression profiling and recent 
functional experiments reveal surprising roles for cTM in the healthy heart. These 
processes include clearance of tissue debris [8], electrical conduction [9], angiogenesis 
[10], fibrosis [11, 12] and maintenance of immune quiescence [12, 13]. We review here 
the functions of microglia and cTM during CNS and heart homeostasis, and focus on 
relevant properties of these cells: their origin, phagocytic and trophic functions, and other 




Ontogeny of Microglia and Cardiac Macrophages  
The last decade has revolutionized our understanding of macrophage development, 
primarily by challenging the notion that tissue macrophages are monocyte-derived. Fate-
mapping studies demonstrated that a significant number of macrophages are derived 
from primitive precursors that arise in the yolk sac [14, 15]. These macrophages or their 
progenitors seed tissues before birth and proliferate to populate the growing tissues, with 
negligible or only minimal dependence on circulating monocytes [14, 16]. Microglia has 
a very low rate of replacement in steady-state in adult animals as evidenced by 
transplantation, parabiosis and lineage-tracing studies, and it is considered as a 
prototypical example of a yolk sac-derived macrophage with minimal dependence on 
adult hematopoiesis [14, 15, 17, 18] (Figure 1). Similarly, most macrophages in the 
spleen, peritoneum, liver, and lung appear to be maintained by embryonic precursors 
that take residence in tissues before birth, independently of adult hematopoiesis [14, 15, 
19]. cTM have been proposed to also belong to this type of macrophages [20], although 
there is some controversy as discussed below.  Other adult tissues, including regions of 
the skin and intestine, continue to be colonized by monocytes through adulthood, such 
that these tissue-resident macrophage populations are ultimately derived from adult 
hematopoiesis [21, 22]. We discuss here the ontogeny and specification of microglia and 
cTM. 
 
Microglia: origin and environment  
Different populations of myeloid cells have been described to inhabit the CNS. These 
populations include non-parenchymal macrophages such as perivascular, subdural 
meningeal and choroid plexus macrophages, and by parenchymal myeloid cells mainly 
formed by microglia [23]. Microglia respond to various brain insults, adopt activated 
phenotypes and secrete a range of cytokines and neurotrophic factors to modify 
disease progression [24]. Microglia, like other tissue-resident macrophages, originate 
from Erythro Myeloid Progenitors (EMPs) that emerge in blood islands  in the yolk sac 
early during development, and gain their microglia-specific transcriptional profile only 
upon migration into the CNS [16-18, 25]. In humans, microglial cells can be identified in 
the extracerebral mesenchyme as early as 4.5 gestational weeks and invade the 
parenchyma at around the fifth weeks [26, 27]. In rodents, microglia precursors defined 
by expression of CSF1R and CD45 but not cKit (CSF1R+CD45+c-Kit-) start seeding the 
neuroectoderm as early as embryonic day 9.5 [18]. Following CNS colonization and 
establishment of its cellular identity, microglial cells self-renew stochastically in the 
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healthy brain and expand clonally during pathology [28] (Figure 1). An elegant 
demonstration of the embryonic origin of microglia and its potential implications in human 
neurodegenerative disease was the observation that mosaic expression of the 
BrafV600E allele in the resident macrophage lineage during early embryonic 
development (E8.5) gives rise to ERK-activated microglia that causes neuronal loss and 
late-onset neurodegeneration [29]. 
  
Although microglial cells share expression of several important genes with other 
mononuclear phagocytes, they have a unique signature defined by genes such as 
P2ry12 and P2ry13, Tmem119, Gpr34, Siglech or Trem2 [30]. In addition to intrinsic 
signals, the local environment is a key influence in shaping the microglial phenotype 
Transcriptional and epigenetic studies have shown that microglia gene signature is not 
as dependent on individual factors such as age, sex or disease status as it is on the 
correct environment with its identity-defining factors PU.1, IRF or AP-1. These findings 
suggest a model by which microglia establishes its identity and function through 
intersecting developmental and environmental networks [31]. 
 
The CNS microenvironment displays important variations in neuronal subtypes, 
neurotransmitter profiles, hemodynamics and type of metabolism that likely influences 
the local microglial phenotype. In this regard, a genome-wide analysis of microglia from 
discrete brain regions found that microglial cells have distinct regional identities [32]. 
Specifically, expression profiles in the cerebellum and hippocampus are relatively distant 
from those of the cerebral cortex and striatum, which share a closer relationship. 
Interestingly, while the cerebellar immunophenotype become more differentiated with 
age, differences in the hippocampal phenotypes dissipate [32]. Microglia residing in the 
Subventricular Zone (SVZ) and the adjacent rostral migratory stream (RMS) also 
comprise a morphologically and antigenically distinct subset. For example, SVZ/RMS 
microglia is clearly distinguishable by low expression of purinoceptors and lack of ATP-
elicitable chemotaxis [33]. 
 
Regional variations in microglia density have also been reported. Highly populated areas 
include the hippocampus, olfactory telencephalon, basal ganglia and substantia nigra 
[34]. Moreover, in vivo fate mapping to visualize the proliferative dynamics identified high 
proliferation frequencies in the olfactory bulb, hippocampus and cerebellum, a finding 
that has challenged the prevailing concept of microglial longevity, which considers 




It is likely that the “sensome”, the set of genes used by microglia to sense their 
environment, could be responsible for the transduction of signals that mediate this 
phenotypic and functional variability. The sensome comprises around 100 genes that 
allow microglia to sense chemokines and cytokines, purinergic molecules, inorganic 
substances, changes in pH and amino acids [30]. Moreover, microglia express numerous 
types of neurotransmitter receptors [35], a finding that suggests that interneuronal 
communication can also have indirect effects on the neighbouring microglia that 
surround the active synapse. 
 
Ontogeny of cardiac macrophages 
The heart is composed of multiple cell types including cardiomyocytes, cardiac 
fibroblasts, endothelial cells, smooth muscle cells, and immune cells, which constitute 
around 10% of non-myocytic cells in the heart [36]. GFP expression in CX3CR1GFP/+ 
reporter mice allowed visualization of cTM in the normal myocardium, where they 
account for a large fraction of total leukocytes [13]. To date, cTM heterogeneity has been 
proposed based on the expression of different markers and on their ontogeny. Although 
the extent of cTM heterogeneity remains incomplete, most of these cells express bona 
fide tissue macrophage markers such as F4/80, CX3CR1, CD68 and CD64 [13, 20, 37]. 
cTM are interspersed between cardiomyocytes, in perivascular areas [13], and in the 
epicardium [38]. The initial seeding of fetal yolk macrophages to the developing heart is 
through the mesothelium, a structure within and just below the epicardium. Accordingly, 
epicardial ablation results in defective macrophage settlement in the heart [39].  
 
The ontogeny of cTM has been addressed by genetic fate mapping and parabiosis [20, 
40, 41]. Lineage-tracing analysis revealed that primitive macrophages originating from 
yolk sac progenitors entered the heart via FLT3-independent pathways as early as E9.5–
E10.5. Genetic labelling at E8.5 using Runx1CreER or Csf1rCreER models showed that 
significant numbers of these cells persisted well into adult life [20]. A second wave of 
macrophages originating from fetal liver hematopoietic progenitors appears in the heart 
through a mix of FLT3-dependent and independent mechanisms at late developmental 
stages [20]. Similar results were obtained using CX3CR1-induced labelling [41]. These 
studies showed that early yolk-sac-derived macrophages persist longer in the heart than 
in other tissues, suggesting a largely embryonic origin for these cells in the adult. After 
birth, cTM expand and are maintained by local proliferation [20, 38, 40]. This is consistent 
with studies showing that the contribution of blood monocytes to the resident 
macrophage pool is minimal even after 4-8 weeks in parabiosis [20, 40, 41]. The 
interpretation of these results varies between groups: some support the idea of the 
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cardiac pool as a closed, embryonically derived system with low contribution of adult 
hematopoiesis [20, 40], while others interpret it as a progressive substitution of 
embryonic derived macrophages by monocyte-derived macrophages with age [41]. 
Supporting the latter, both circulating monocytes as well as residual cTM contribute to 
repopulate the heart after severe inflammation [41], angiotensin II infusion, sub-lethal 
irradiation or depletion of cTM [20]. Interestingly, self-renewal of the embryo-derived cTM 
pool declines with age, and may allow progressive replenishment by circulating 
monocytes, even in the absence of injury [41]. Additional studies will be needed to sway 
the weight of evidence one way or the other (Figure 1). 
 
Like in the brain, various populations of macrophages reside in the myocardium. Using 
a combination of flow cytometry, tissue immunostaining, and genetic lineage tracing, 
Leid et al. showed that the developing heart contains at least two macrophage subsets 
that can be subdivided on the basis of expression of the chemokine receptor CCR2 [10], 
which are similar to populations found in the adult [20]. In the embryo, CCR2-negative 
(CCR2-) macrophages overexpress transcripts previously associated with yolk sac–
derived and resident macrophage subsets (e.g., Cx3cr1, Lyve1, Emr1, Cd207, 
and Ccl12), while the CCR2-possitive (CCR2+) subset shows increased expression of 
monocyte-derived macrophages transcripts, including Ly6c, Cxcr2, Sell, Irf5 
and Nr4a1 [10]. During development, CCR2+ and CCR2− cTM occupy different locations, 
with CCR2− cells residing predominantly in the myocardial wall and CCR2+ mostly found 
in trabecular projections of the endocardium [10]. Interestingly, these subsets appear to 
be functionally specialized; CCR2- macrophages are recruited to coronary vessels at the 
onset of perfusion and participate in remodelling of the coronary plexus through selective 
expansion of the perfused vasculature, and are therefore important for normal cardiac 
development. In contrast, CCR2+ macrophages are dispensable for this process [10].  
 
Together, these data argue that cTM exist independently from blood monocytes in the 
steady-state and self-renew through in situ proliferation with low monocyte input, with an 
estimated turnover of about one month [40]. When cTM are depleted, they preferentially 
replenish through both local expansion and monocyte replacement to differing degrees. 
This shift in the source of cardiac macrophages through development, disease and aging 
is biologically intriguing and discussed below.  
 




The word “macrophage” derives from the Greek “makros” (large) and “phagein” (eater). 
True to their name, macrophages are highly phagocytic, as first discovered by Elie 
Metchnikoff in 1882. While macrophage ontogeny and activity are highly heterogeneous 
[42], all macrophages participate in the clearance of tissue debris as well as the detection 
of pathogens and tissue damage. Many of the homeostatic roles of macrophages rely 
on their ability to phagocytose. Specifically, microglia-mediated phagocytosis plays an 
important role in brain development, synaptic pruning and in the maintenance of the 
neurogenic niche. In the case of cTM, their phagocytic activity has been associated with 
debris clearance and immune defense. Specific mechanisms of phagocytosis will not be 




Synaptic pruning: Microglia are the brain’s professional phagocytes. They can remove 
dead and dying neurons as well as synapses and cellular processes of live neurons. 
Two-photon imaging of GFP-labelled microglia showed that the termini of microglial 
extensions are highly dynamic in the intact mouse cortex [44]  Multiple components of 
the neuronal synapses are a major target of microglia surveillance, and interactions of 
microglia and synapses have been described in several settings [3, 45, 46]. Using 
models with fluorescent-labelled neurons and microglia, Wake and colleagues 
demonstrated that cellular extensions from resting microglial cells make brief contacts 
(approximately 5 min) with neuronal synapses at a frequency of about once per hour, 
which are prolonged following cerebral ischemia [46]. In the visual cortex, physical 
contacts between microglia and dendritic spines were demonstrated to change 
morphology, display phagocytic structures and to envelope synapse-associated 
elements during visual experience, suggesting that microglia actively contribute to 
experience-dependent modification or elimination of a specific subset of synapses in the 
healthy brain [45].  Super-resolution imaging demonstrated that post-synaptic density 
protein-95 (PSD95, now known as DLG4) was present within microglial processes in the 
mouse hippocampus during normal development, suggesting that microglia can uptake 
pre- or postsynaptic material [3]. Consistent with a role of microglia in this process, mice 
lacking the chemokine receptor CX3CR1, which exhibit a transient reduction of microglia 
during the early postnatal period, presented a deficit in synaptic pruning [3]. This defect 
was later associated with weak synaptic transmission, decreased functional brain 
connectivity, deficits in social interaction and increased repetitive-behavior phenotypes 
[47], establishing a link between microglia and neurodevelopmental disorders. 
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Complement proteins C1q and C3 mediate the specific interactions of microglia with 
neuronal synapses [4]. Complement proteins are localized in developing CNS synapses 
during periods of active synapse elimination and are required for normal brain wiring [48]. 
Seminal studies on the formation of synaptic connections in the retinothalamic system 
during early postnatal development identified the complement protein C1q or the 
downstream complement protein C3 as important mediators of synapse elimination [49]. 
Phagocytosis of the developing synapses tagged with complement proteins was 
mediated through the complement receptor 3 (CR3, also known as Mac-1), and 
consequently disruption of microglia-specific CR3/C3 interactions resulted in sustained 
deficits in synaptic connectivity [4]. Retinal transforming growth factor (TGF)-β has 
been proposed as a key regulator of neuronal C1q expression because mice lacking 
TGF-β receptor II (TGFβRII) in retinal neurons present reduced C1q expression in 
retinal ganglion cells together with a reduced synaptic localization of complement 
proteins, which phenocopy the synaptic defects observed in complement-deficient 
mice [50].  
In addition to C3, CR3 also recognizes various types of neuroinflammatory stimuli such 
as lipopolysaccharide (LPS), β amyloid, high-mobility group box 1 (HMGB1) or α-
synuclein, all of which can cause neurotoxicity. Interestingly, activation of microglial CR3 
by LPS and hypoxia triggers long-term synaptic depression in the hippocampus, an 
effect that may contribute to memory impairments and synaptic disruptions in 
neuroinflammation-related brain disorders [51]. In addition, inappropriate activation of 
the complement-dependent pathway has been proposed to mediate synapse loss in 
experimental models of Alzheimer’s disease (AD) [52]. These evidences suggest that 
immune activation of microglia during neuroinflammation impairs brain function, and 
highlights the importance of these cells in sculpting the neuronal networks. Accordingly, 
complement proteins are strongly upregulated in neurodegenerative disorders such as 
AD, glaucoma, and amyotrophic lateral sclerosis [53-55] (Figure 2).  
 
Neurogenesis: In addition to synaptic pruning, microglia-mediated phagocytosis of 
neurons is an important process to shape neural circuitries. During development, 
programmed cell death occurs among neuronal subsets [56], including both postmitotic 
neurons and proliferating neuroblasts. Tracking of dying cells by microglia is thought to 
be mediated by exposure of “eat me” signal at the surface of neurons. One of the best 
studied “eat me” signals is phosphatidylserine (PS), a plasma membrane lipid that is 
‘flipped-out’ and exposed on the surface of apoptotic cells [57]. Scavenger receptors 
(e.g., CD36 or SRA-1), integrin αvβ3, Mer, TIM-1 and 4, BAI1, and Stabilin1 and 2 have 
all been shown to act as PS receptors [58]. Studies of neuron engulfment by microglia 
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in embryonic zebrafish brains indicate that microglia phagocytose dying neurons by 
extending cellular branches that form phagosomes at their tip in a BAI1 and TIM-4 
dependent fashion [59]. In mice, microglial-mediated phagocytosis in the adult 
neurogenic niche relies on PS recognition by the TAM receptors Mer and Axl, and adult 
mice lacking these receptors exhibit a marked accumulation of apoptotic cells in 
neurogenic regions of the CNS [60]. Similar findings were made in mice lacking Gas6 
and ProS, two bridging proteins that mediate PS recognition by TAM (Tyro3/Axl/Mer) 
family receptors [60]. This phagocytic mechanism mediated by Mer is analogous to the 
one employed by retinal pigment epithelial cells to phagocyte photoreceptor outer 
segments [61] or by astrocytes that engulf CNS synapses [62], indicating that TAM-
mediated phagocytosis is a general supportive function that reshapes neuronal circuits 
by different CNS cell types.  
In the neurogenic niches of the adult mouse brain, rapidly dividing transit-amplifying cells 
are constantly producing new neurons of which only a small proportion integrates into 
the neural circuitry of the hippocampus or in the granule and glomerular cell layers of the 
olfactory bulb [63]. In the adult hippocampus, newborn neuroblasts are rapidly cleared 
out through phagocytosis by unchallenged microglia present in the adult subgranular 
zone [64]. This capacity of microglia to phagocytose neuronal progenitors seems to be 
required for normal neurogenesis, because disruption of engulfment in vivo leads to an 
accumulation of apoptotic nuclei in the neurogenic niches and generally impairs 
neurogenesis [65]. The importance of microglia in maintaining homeostasis of the 
neurogenic cascade could be of mayor significance in processes of memory, depression, 
and neurodevelopmental or neurodegenerative disorders such as Alzheimer's and 
Parkinson's disease. In this regard, microglial expression of Axl is prominently 
upregulated in the inflammatory environment that develops in a mouse model of 
Parkinson's disease [60], and augmentation or repopulation of brain phagocytes, or 
improvement of their phagocytic activity, has been shown to arrest pathology in a mouse 
model of Rett Syndrome [66]. 
 
Phagocytosis and pathology: As described above, unchallenged microglia phagocytose 
apoptotic cells during development and in adult neurogenic niches. However, microglial 
phagocytosis has been traditionally studied under inflammatory conditions leading to the 
assumption that microglia needs to be activated in order to become phagocytic. Under 
inflammatory conditions, specific PS-binding opsonins and their receptors are strongly 
upregulated, enabling potent detection and phagocytosis of PS-exposing cells [67]. As 
an example, Mer and Milk fat globule EGF-like factor 8 (MFGE8) are transiently up-
regulated following focal brain ischemia and deficiency in either receptor completely 
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prevents long-term functional motor deficits and strongly reduces brain atrophy as a 
result of inhibiting phagocytosis of neurons [68]. This results challenge the traditional 
notion that phagocytosis of dead or dying neurons from the infarcted brain may be 
beneficial by clearing harmful cellular components and decreases inflammation. In this 
regard, it appears that inflammatory activation of microglia impairs their ability to 
discriminate between apoptotic and viable neurons for phagocytosis, resulting in 
phagoptosis during inflammation [67].  
Beyond phagocytosis of neurons, microglia activation during inflammatory conditions 
has an important role in phagocytosing infiltrating leukocytes to the inflamed tissue. Time 
lapse imaging on organotypic brain slices showed that microglia rapidly engulf apoptotic 
and also viable motile neutrophils, thus mediating neuroprotection against the neurotoxic 
effects of these leukocytes [69]. Clearance of neutrophils was shown to be important for 
neuroprotection after stroke [70, 71]. In addition, microglia exhibits a high capacity to 
uptake apoptotic autologous thymocytes, as well as apoptotic autoreactive T cells [72], 
myelin debris [73] or amyloid beta [74]. These observations raise important issues on 
the therapeutic manipulation of microglial phagocytosis, because detrimental effects 
could be achieved. On one hand, enhanced phagocytosis of synapses and viable 
neurons by microglia impairs CNS homeostasis [51-53, 68], but on the other 
phagocytosis can ameliorate CNS-related pathologies [66, 70, 72-74] and it is necessary 
for the correct functioning of the neuronal circuitry [3, 4, 32, 45, 46, 64, 65]. Further work 
will be needed to further establish how microglia-mediated phagocytosis is shaped by 
environmental signals or pathological conditions. In this regard, recent studies on AD 
using transcriptomic on single-cells identified a novel microglia type associated with 
neurodegenerative diseases (disease-associated microglia or DAM) with a unique 
potential to restrict neurodegeneration [74]. In a physiological context, microglial 
heterogeneity may be confined to distinct brain regions at sites where they interact with 
specific neurovascular structures. Whether the emergence of the DAM phenotype is 
restricted to a specific microglia population or if it is transiently acquired during 
neurodegeneration, as well as the signals that induce this phenotype, remain open 
questions (Figure 2).  
Further studies have investigated the differential role of resident microglia and infiltrating 
monocytes to the inflamed CNS in the progression of neurodegeneration [75-78]. 
Disruption of the blood-brain barrier during inflamation has a high impact on the 
heterogeneity of the CNS phagocyte subsets due to infiltration of HSC-derived 
monocytes into the CNS parenchyma. Infiltrating monocytes are thougth to play different 
functions compared with microglia during the acute inflammatory response. In the onset 
of experimental autoinmune encephalitis (EAE), the phagocytic activity of monocytes has 
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been associated with the initiation of demyelinization, whereas microglia appeared to 
clear debris [77]. Differences have been also reported in the context of stroke, where 
changes in the expression profiles between microglia and macrophages 72 hours post-
ischemia indicated that proinflammatory cytokines were preferentially upregulated in the 
infiltrating myeloid population [78].  
Despite their vigorous accumulation during neuroinflammation, bone marrow-derived 
cells do not contribute to the pool of microglia  as they are thought to disappear during 
resolution [79]. However, long-term engraftment of bone marrow-derived macrophages 
can take place in the brain when microglia are impaired in their ability to repopulate the 
niche. In these conditions, brain-engrafted macrophages do not alter behaviour but 
display a different transcriptional signature when compared to microglia [80]. 
 
Phagocytosis by cardiac macrophages 
 
Incorporation of cardiomyocyte-derived material: Contrary to microglial cells, little is 
known about the phagocytic role of cTM in the steady state heart. Recent studies have 
explored the transfer of cardiomyocyte-derived material into cTM using MHC-reporter 
mice to fluorescently label cardiomyocytes. Results from these experiments indicate that 
cTM can incorporate large amounts of cardiomyocyte-derived material in vivo, even in 
the unperturbed hearts [8]. In this settings, a cTM subset expressing low levels of the 
major histocompatibility complex II (MHCIIlo) was phagocytically more active than other 
subsets both in vitro and in vivo [8, 20]. This result is striking given the low renewal rate 
of adult cardiomyocytes [81], and the lack of cardiomyocyte precursors. It will be 
interesting to assess if this transfer of material from the cardiomyocyte is caused by a 
“trimming” process similar to synaptic pruning mediated by microglia in the brain [3], and 
to define the possible mediators of this type of phagocytosis in the heart. More important, 
the phagocytic content and the physiological consequences of cTM phagocytosis for 
heart homeostasis are currently unknown and deserve further studies (Figure 3). 
While phagocytosis in the healthy myocardium has received little attention, studies in 
injured hearts reveals extensive functions of macrophages in clearance of damaged 
material and myocardial remodelling. In the context of myocardial infarction (MI), cTM 
disappear in the first 24 hours, and are replaced by monocyte-derived macrophages [40]. 
Although monocyte-derived macrophages evoke tissue inflammation early after MI, they 
also have phagocytic activity against infiltrating inflammatory cells (i.e. neutrophils) that 
die in situ [82], cardiomyocyte-derived debris and against other apoptotic cells [83]. 
Given the anti-inflammatory properties of phagocytosis, disruption of this function in the 
infarcted myocardium can result in failed myocardial remodelling [84]. Conversely, 
attempts have been made to stimulate this beneficial property elicited by phagocytosis 
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using PS-expressing liposomes that mimic apoptotic cells [85]. In the post-infarcted heart, 
this treatment reduced the expression of the pro-inflammatory genes TNF and CD86, 
and increased expression of CD206, TGF-β and IL-10, all of which have anti-
inflammatory and pro-healing properties. As a result, liposome-treated hearts displayed 
increased angiogenesis, reduced infarct area, and improved cardiac function [85]. In the 
same direction, studies analysing the effect of macrophage depletion with clodronate in 
the context of MI, showed a net beneficial role for macrophages in scar formation after 
MI, given that macrophage-depleted mice display poor infarct healing and myocardial 
rupture [86]. 
 
Macrophages are endowed with several molecules/mechanism to detect apoptotic cells 
that can work synergistically or independently [87]. Mutants in both Mer and Mfge8 
molecules have larger infarcts, increased accumulation of apoptotic cells, enhanced 
fibrotic area, reduced angiogenesis and worse outcomes than either single mutant mice 
[88]. In contrast, macrophage-borne Mer appears to be necessary and sufficient for 
efferocytosis of cardiomyocytes ex vivo [89] (Figure 3). In infarcted human hearts, the 
expression of this receptor increases in necrotic areas, mimicking what is found in 
experimental ischemic mouse hearts. Supporting the role of Mer in the phagocytosis of 
necrotic cardiomyocytes, Mer-deficient macrophages contain reduced myocyte debris 
after MI [90]. Surprisingly, ex vivo co-culture of primary macrophages and adult 
cardiomyocyte apoptotic bodies revealed that phagocytosis of cardiomyocyte-derived 
material was inefficient. This was associated with myocyte-induced inactivation of Mer, 
while genetic elimination of a proteolytic site that enhances functional expression of Mer 
partially rescued this defect [90]. Further supporting this idea, an inactive form of Mer 
(solMER) was identified in the infarcted myocardium, implicating a natural mechanism of 
Mer inactivation after MI [8, 89]. In contrast, a cleavage resistant form of Mer improves 
MI outcome by enhancing efferocytosis [8]. Because uptake of cell debris by 
macrophages after MI has been shown to induce IRF3 and type I IFN production, which 
are detrimental for post-MI recovery, limiting phagocytosis in the infarcted myocardium 
may be a way to control macrophage activation and to protect heart function [91]. 
 
Immune defence and immune quiescence: In the adult heart, cTM are one of the first 
lines of defense against infections by direct ingestion of bacteria [40]. Exposure to the 
type-2 pathogens Schistosoma mansoni or Heligmosomoides polygyrus results in 
increased macrophage density in the heart, adoption of a stellate morphology, and 
increased expression of Ym1, RELMα and CD206, which is indicative of M2-like 
polarization. This was dependent on the recruitment of Ly6Chigh CCR2+ monocytes, 
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suggesting that changes in cardiac macrophage pool could occur through de novo 
recruitment of monocyte-derived macrophages with different phenotypes and immune 
functions [92].  
cTM-mediated phagocytosis also participates in immune quiescence by performing non-
phlogistic elimination of cellular debris and dead cells, which could otherwise cause 
inflammation by the release of intracellular contents (reviewed in [12]). In the steady state, 
cTM produce factors such as C1q and galectins [13] that directly bind apoptotic cells and 
antibody-bound targets thus eliciting phagocytosis [93], while simultaneously dampening 
inflammation [94]. cTM also produce lipoxin A4, resolvin E1 and protectin D1 [13], which 
promote non-phlogistic phagocytosis by directly stimulating macrophages to further 
phagocytosis and by inhibiting the production of inflammatory cytokines [95, 96]. These 
findings suggest that cTM may inhibit aberrant inflammatory reactions in the heart to 
maintain tissue homeostasis [13]. In agreement with this possibility, macrophages in the 
healthy heart have been shown to express molecules associated with an 
immunomodulatory phenotype, including cytoprotective factors such as IGF-1 and 
immune repressors such as IL-10 [13] (Figure 3). 
 
Trophic functions: influence on tissue homeostasis  
 
 
The secretory microglia  
 
Microglia has the ability to react rapidly to modifications of their environment by secreting 
soluble factors. Its close association with neurons and astrocytes and other cell types 
suggests an involvement of microglia-released products in several homeostatic 
processes in the CNS. Indeed, a wealth of reports have demonstrated that microglia-
derived soluble factors influence development, inflammation, synaptic activity, 
oligodendrogenesis, astrocyte differentiation or sensitivity to pain (Figure 2).  
Regulators of neuronal cell death: Neurons require trophic support during the formation 
of neural circuits. Factors produced by the microglia can deliver these signals as they 
constitutively release different cytokines. This release is highly sensitive to 
environmental conditions and can augment by several orders of magnitude in response 
to certain stimuli. Early in vitro studies demonstrated that co-culture of neurons from 
various CNS regions with microglia or with microglia-conditioned medium promoted 
neuronal survival and neuritic extension [97-99]. In the mouse brain, Ueno and 
colleagues described that layer V cortical neurons require support from microglia for 
survival during postnatal development. Microglia near the subcerebral and callosal 
projection axons in the postnatal brain secretes insulin growth factor 1 (IGF1), which 
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inhibits caspase-3-mediated apoptosis of neurons [100]. In line with these findings, 
studies during embryonic development found that microglia localizes at decision points 
along specific axonal tracts. For instance, microglia transiently associates with the 
extremities of tyrosine-hydroxylase (TH)-positive midbrain dopaminergic axons, and 
perturbation of microglial activity affects the outgrowth of dopaminergic axons in 
the forebrain and the laminar positioning of subsets of neocortical interneurons [101]. In 
contrast, microglia can induce retinal ganglion cell death in the developing chick retina 
by releasing nerve growth factor (NGF) [102]. Thus, microglia-derived factors can 
differentially modulate neuronal survival during brain development. 
Following inflammation, microglia activation is normally accompanied by partial 
retraction of processes to the cell body, proliferation, and expression and release of pro- 
inflammatory cytokines, including TNF, IL-1β, IL-6 and IFN-γ. All these molecules have 
been shown to amplify the inflammatory response and to drive neuronal cell death in 
different pathological conditions [103]. Microglial secretion of Il-1α, TNF and C1q also 
induces a subtype of reactive astrocytes termed A1, which contribute to the death of 
neurons and oligodendrocytes in neurodegenerative disorders [104].  A1 astrocytes lose 
their ability to promote neuronal survival, outgrowth, synaptogenesis and phagocytosis, 
and secrete a yet-to-be-identified toxin that kills neurons and oligodendrocyte [104]. 
Further studies have suggested a role for the microglial-astrocytic-neuronal axis in 
neurodegenerative diseases and cognitive dysfunctions. In this context, Habbas and 
colleagues demonstrated that TNF triggers an astrocyte-neuron signalling cascade 
resulting in persistent functional modification of synapses that mediates hippocampal 
synaptic alteration and contextual learning-memory impairment during EAE [105]. TNF 
secretion by microglia was suggested to be the prime event for this alteration as this 
cytokine is mainly secreted by activated microglia during EAE [106]. In addition to 
cytokine release, recent reports in the context of AD have shown that inflammation 
triggers microglia release of the inflammasome adaptor protein ASC (Apoptosis-
associated speck-like protein containing a CARD), which binds rapidly to amyloid-β and 
increases the formation of amyloid-β oligomers and aggregates spreading pathology 
[107].  Contrasting with these pathogenic functions, microglial activation during 
inflammation has also been proposed to promote neuroprotection by releasing anti-
inflammatory molecules and growth factors including NGF, brain-derived neurotrophic 
factor (BDNF) or neurotrophin-3 (NT-3) [108]. All these evidences point to the microglial 





Synaptic partners: Microglia also maintain synaptic plasticity by releasing various soluble 
molecules. Among them, BDNF has emerged as a mediator of microglia-induced 
disinhibition of neuronal excitability by disrupting Cl− homeostasis [109]. This effect is 
crucial in the pathogenesis of pain hypersensitivity after injury to peripheral nerves. Coull 
and colleagues demonstrated that ATP stimulation of P2X4 receptors in microglia 
initiates a core pain signalling pathway mediated by the release of BDNF, which causes 
collapse of the transmembrane anion gradient in spinal cord neurons [5]. These 
evidences indicate that neuropathic pain critically depends on microglia-to-neuron 
signals, which alter GABA/glycine-mediated inhibition.  
 
Further studies have implicated microglial cells in the modulation of synaptic 
transmission; microglia-astrocyte crosstalk modulates excitatory neurotransmission in 
hippocampal slices [110]. Activation of microglia induces a rapid increase of 
spontaneous excitatory postsynaptic currents through release of small amounts of ATP, 
which targets astrocytes and leads to and increase postsynaptic current frequency in 
hippocampal neurons [110]. Similarly, microglial release of ATP and glutamate has also 
been described in zebrafish in the context of acute injury [111]. Increased production of 
glycine and serine by microglia has been also suggested to enhance long-term 
potentiation responses in hippocampal neurons in vitro [112]. Moreover, microglia have 
been suggested to play a role in synaptic scaling, a type of homeostatic plasticity that 
entails uniform adjustments in the strength of all synapses of a neuron in response to a 
prolonged stimulus. In this setting, TNF has been proposed to mediate synaptic scaling 
in response to prolonged blockade of activity [113]. Because both astrocytes and 
microglia can produce TNF, the relative contribution of these two cell types to this 
phenomenon remains unclear.  
 
These studies show that microglia is a modulator of glutamatergic or GABAergic synaptic 
transmission, either directly (neurons) or indirectly (astrocytes), through the release of 
soluble mediators. It is important to note that several other molecules produced by 
microglia, such as cytokines (IL-1, TNF), gaseous molecules (nitric oxide) or lipidic 
mediators (prostaglandins) can also modulate synaptic transmission and further studies 
are needed to determine their role during microglia-to-neuron communication. Since 
pathological activation of microglia and alteration of neurotransmission are two early 
symptoms of brain disorders, it is likely that dysregulated microglia secretion underlies 




Microglia and CNS cell differentiation: Neural stem/progenitor cells (NSPC) proliferate 
and differentiate depending on their intrinsic properties and local environment and 
microglial cells are closely associated with NSPC in the neurogenic niche. Although the 
precise cellular and molecular interplay between microglia and NSPC in vivo are still 
poorly understood, available data indicate that the effect on NSPC is mainly mediated 
by soluble factors rather than by cell-to-cell contact. Among these factors, pro-
inflammatory cytokines (e.g. IL-1β, TNF and IL-6) impair neurogenesis, whereas anti-
inflammatory cytokines (IL-4 and IL-15) and trophic factors (IGF-1, BDNF) are 
proneurogenic [114]. Thus, the activation state of microglia affects NSPC differentiation 
in different ways: IL-6 and leukemia inhibitory factor (LIF) released by activated microglia 
promote astrocytic differentiation of NSPC [115], whereas resting microglia inhibits the 
differentiation of human NSPC towards neurons [116].  
In vitro studies also suggest that differentiation of oligodendrocyte precursors can be 
influenced by microglia [117]. CSF-1R mutant mice display a prominent reduction in the 
number of Nogo1+ oligodendrocytes in the cerebral cortex and hippocampus [118], an 
observation that correlates with highly activated amoeboid microglia in myelinating 
regions of the murine brain during early postnatal stages, and with the finding that 
inhibition of CSF-1R reduces the number of oligodendrocyte precursors in the corpus 
callosum [119]. However, the specific microglia-derived molecules that induce 
oligodendrocyte progenitor survival and differentiation to oligodendrocytes during brain 
development have not been identified. In the context of lysolecithin-induced injury, 
microglia promotion of oligodendrocyte differentiation is proposed to involve arginase 
1-expressing microglia that secrete activin A to trigger regeneration [117]. 
 
cTM: a secretory cell with potential homeostatic functions 
The interspersed localization of cTM between cardiomyocytes places them in a 
privileged position to exchange signals with these cells. Like microglia, cTM release 
products that have been proposed to regulate cardiac physiology. Conditioned media 
from CCR2− macrophages induces neonatal rat cardiomyocyte proliferation in vitro [120]. 
This effect may be critical under hypoxic conditions because an increase in CCR2- 
resident macrophages induces cardiomyocyte proliferation in neonate human and 
animal models during hypoxia [121], suggesting that cTM regulate cardiomyocyte growth 
and division. One interesting candidate to mediate these effects is IGF-1, which is highly 
expressed by cTM when compared with other resident macrophage populations of the 
brain or the spleen [13]. IGF-1 is know to have an effect in cardiomyocyte proliferation 
since its overexpression under the control of alpha-myosin heavy chain (MHC) 
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promoter, a cardiomyocyte-specific gene, led to increased numbers of myocytes and 
cardiomegaly [122], an effect that was latter associated with the Hippo signaling pathway 
in the context of heart development [123]. However, a direct link between cTM-mediated 
IGF-1 production and cardiomyocyte proliferation has not been formally demonstrated 
(Figure 3). 
cTM also contribute to cardiac fibrosis, a hallmark of cardiac senescence that increases 
with age [38]. cTM secrete a number of pro-fibrotic factors such as Retnla, Ccl24, 
Osteopontin and Tgf1b that may induce fibroblast proliferation and collagen deposition 
by both TGFβ-dependent and -independent pathways [11, 38]. In addition, expression 
of these genes by cTM increases with age, particularly at the epicardium, suggests that 
cTM-mediated ECM remodelling influences cardiac ageing [38]. Accordingly, cTM have 
been found to affect diastolic function of the heart by controlling extracellular matrix 
deposition by fibroblasts [11]. These evidences, as with microglia, suggest trophic roles 
for cTM in heart homeostasis and highlight a potential role for these resident cells in 
many more cardiac processes than previously anticipated.   
 
Cell-to-cell contact: CNS vascular networks and electrical conduction in the 
heart 
 
Histologically, macrophages form grids within tissues and organize in regular networks 
with long cytoplasmic extensions (filopodia) that project around specialized tissue cells 
such as epithelial cells, neurons, endothelial cells or cardiomyocytes. Their unique 
spatial localization within the brain and cardiac tissue allows them to establish narrow 
and physical interactions with other constituents of the tissular architecture. Two different 
mechanisms associated with cell-to-cell contact of macrophages with parenchymal cells 
in those organs have been reported. One is regulation of angiogenesis [124] by serving 
as a bridge to promote endothelial cell tip fusion in the brain; the second is to favour 
electrical conduction by cTM that form direct connections with cardiomyocytes [9]. 
 
Angiogenesis and tip cell fusion 
Macrophages have been proposed to play an important role during developmental 
angiogenesis. Fentin and collaborators combined the analysis of mouse mutants 
defective in macrophage development or VEGF signaling with live imaging in zebrafish 
to show that macrophages in the developing brain promote endothelial tip cell fusion 
[124], an effect that was necessary for vascular network formation. Indeed, PU.1- or 
CSF1-mutant mice that lack microglia displayed reduced complexity of the brain vascular 
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network early in development [124]. This has been additionally shown to be dependent 
on hypoxia-induced factor 1 (HIF1) signalling during vessel injury because HIF-
deficient macrophages are not able to assist repair of blood vessels [125]. An elegant 
study of vascular injury in zebrafish visualized a process by which macrophages 
mediated repair of cerebrovascular rupture through direct physical interaction with 
endothelial cells. Brain macrophages were proposed to generate mechanical traction 
forces that brought together endothelial ends and facilitated their ligation, because 
depolymerization of microfilaments and inhibition of phosphatidylinositide 3-kinase or 
Rac1 activity in macrophages impaired cerebrovascular repair [126].  
 
The role of macrophages in cerebrovascular remodeling can be also extended to other 
tissues, especially during vascular development, as these intimate interactions between 
macrophages and endothelium occurs all across the developing embryo [124]. In the 
heart, cTM are also in intimate contact with the dense cardiac vascular bed and express 
Nrp1, a positive regulator of angiogenesis [13]. Interestingly, CCR2- cTM are also 
important for the normal development of the coronary vasculature [10] and essential for 
cardiac regeneration following injury in the neonatal heart, presumably by promoting 
angiogenesis [127]. Altogether, these results argue in favour of a proangiogenic role for 
cTM and microglia during development and after injury. These roles rely on direct cell-
to-cell contact but also on the release of proangiogenic factors that assist or promote 
stabilization of endothelial tip cell fusion [128]. These proangiogenic functions could be 
exploited to stimulate tissue vascularization after cardiac infarct or stroke (Figure 2 and 
3). 
 
Modulation of the electrical activity of the heart 
A unique property of the cardiac tissue is its autonomous pacemaker activity that controls 
its beating function. The cardiac conduction system is composed of a specialized group 
of cardiomyocytes responsible for initiating and transmitting electrical activity. The 
sinoatrial node located in the right atrium is the master pacemaker of the heart, which 
sends electrical signals to the atrioventricular node (AVN), a structure that coordinates 
contraction between the upper (atria) and lower (ventricles) chambers. The regulation of 
this unique function has been recently associated with a cluster of cTM localized in the 
AVN region, in the proximity of cardiomyocytes of the conduction system [9]. These 
macrophages form direct gap junctions with cardiomyocytes via connexin 43 (Cx43), and 
depolarize in synchrony with the cardiomyocytes to which they connect. By using patch 
clamp techniques, Hulsmans and collaborators showed that these cells have positive 
effects on the excitability and a shortening of the refractory period of the AVN conduction 
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structure (Figure 3). Elegant optogenetic approaches directed to cTM showed that these 
cells modulated the conducting properties of the AVN. Accordingly, macrophage-
restricted deficiency (using the Cx3cr1CreER driver) in Cx43 or general myeloid cell 
depletion, using the CD11b-DTR model, had similar alterations in electrical conduction 
of the heart, and caused arrhythmias [9]. These surprising findings extend the repertoire 
of support activities that macrophages can exert in a tissue, and reveal a high degree of 
specialization within each organ. 
 
Open questions and concluding remarks 
It is now clear that tissue-resident macrophages are extremely specialized cells whose 
functions extend beyond their roles as immune sentinels. In the brain and heart, they 
sense and respond promptly to environmental changes. Phagocytosis and secretion of 
cytokines, trophic factors and other molecules have a direct impact on both neurons and 
cardiomyocytes. Microglia participate in synaptic pruning, maintenance of the 
neurogenic niche and in cerebral inflammation through their phagocytic activity. 
Secretion of soluble mediators regulate neuronal differentiation, synaptic activity and 
immunity. In turn, phagocytosis of cardiomyocyte-derived material, cellular debris, 
immune cells and pathogens by cTM maintain homeostasis and modulate immune 
responses in the heart. Other sophisticated tasks, such as the regulation of the electrical 
activity of the heart, reveal that, like microglia, cTM are uniquely specialized to support 
the demands of their host organ. 
The many, well-defined mechanisms by which microglia support CNS function, however, 
still contrast with the scarce roles ascribed to cTM in the heart. Nevertheless, we draw 
functional parallelisms between macrophages in these tissues, including their capacity 
to modulate excitatory currents, to phagocytose cellular content or to secrete essential 
factors. Whether these similitudes extend to macrophages in other tissues is unclear, 
but we emphasize that the rigid anatomical constrains and low regenerative potential 
shared by the brain and the heart likely demand special support by dedicated cells in 
both tissues.  
The impact of microglia and cTM alterations on tissue function during disease or aging 
is a major focus of current research. In this regard, ontogenic differences between 
resident microglia and infiltrating monocytes to the inflamed CNS have been linked to a 
differential contribution of both myeloid subsets in the progression of neurodegeneration. 
In the heart, the effect of cTM replacement by monocyte-derived macrophages is still 
unclear. In this regard, recent studies suggest that macrophages at day 30 post-MI and 




Myeloid cell replacement (embryonic vs. adult) and inflammation or aging-mediated 
myeloid cell infiltration could therefore have an impact on the heterogeneity and 
functioning of cTM and microglia and, by extension, on tissue homeostasis. The role of 
cTM on modulating electrical heart conduction [9] and the association of monocyte-
derived macrophages with fibrotic deposition and diastolic dysfunction [11] prompt 
redefinition of the contribution of immune cells to idiopathic cardiomyopathies, and might 
direct generation of novel therapeutics tailored to this organ. Along the same line, 
phenotypic changes in microglia during age and disease, as well as the contribution of 
brain-engrafted macrophages to CNS homeostasis could unveil novel therapeutic 
approaches to fight neurodegeneration. Phenotypic modulation and genetic 
manipulation of brain and heart phagocytes, transplantation of specific myeloid 
progenitors and depletion of deleterious subsets may therefore provide efficient means 
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Figure 1 Origin of microglia and cardiac macrophages. Microglia emerges from yolk 
sac-derived EMPs that colonize the brain early during development. Contribution of 
HSC-derived monocytes under homeostatic conditions is minimal as shown by different 
experimental settings, including parabiosis and fate-mapping. Following inflammation 
microglia proliferates clonally and activates. Disruption of the blood brain barrier leads 
to the infiltration of blood leukocytes to the brain parenchyma. cTM arise from fetal 
precursors that colonize the heart early in development. After birth, a progressive 
substitution of fetal macrophages by blood monocytes has been proposed. In the 
inflamed or aged heart, cTM death and recruitment of blood monocytes have been 


























Figure 2 Microglia functions under homeostasis and inflammation. Complement 
tagged synaptic spines are phagocytosed by microglia leading to synaptic pruning and 
configuration of neuronal networks, especially during development. TGF has been 
proposed as a regulator of neuronal complement expression and C3 expression by 
microglia recognizes tagged synapses. Phagocytosis of neuroblasts and healthy 
neurons by microglia take place through phosphatidylserine (PS) recognition by 
microglial TAM receptors. Microglia released byproducts modulate synaptic activity, 
either directly by releasing BDNF, glycine or serine, or through astrocytes by ATP or 
TNF release. The secretory activity of microglia also controls neuronal differentiation 
and survival, astrocyte activation and oligodendrogenesis. Repair of damaged blood 
vessels and proangiogenic properties form part of microglia functions. During 
inflammatory conditions, upregulation of complement proteins and excessive pruning 
have been proposed to play a role in different CNS pathologies. Upregulation of 
microglia-mediated phagocytosis during inflammation could play a deleterious role 
during stroke. In contrast, improved phagocytic performance of microglia has beneficial 
effects in pathology by phagocytosing amyloid beta, myelin debris and infiltrating 
leukocytes. An increased release of proinflammatory molecules and ASC specks by 
microglia has been related with neuroinflammation and amyloid- oligomerization. 

















Figure 3 Functions of cTM during homeostasis and myocardial injury. cTM couple 
to cardiomyocytes through Connexin43 in the AV node, thus modulating their electrical 
properties. cTM participate in immune defense by directly phagocytosing pathogens, 
thus acting as the first line of defense. cTM also promote immune quiescence by 
performing non-phogistic phagocytosis: cTM release C1q, Galectins and other factors 
that promote removal of debris and apoptotic cells. Release of lipoxin A4, resolvin E1 
and protectin D1 inhibit the production of inflammatory cytokines. cTM produce high 
levels of IGF-1, likely acting on neighboring cardiomyocytes and regulating their 
metabolic activity and survival. After myocardium infarct, cTM phagocytose necrotic and 
apoptotic cells through Mer receptor and contribute to healing. Vascular remodeling and 
selective expansion of perfused vascular beds in the coronary plexus are also mediated 
by cTMs, especially during embryonic development. cTM have been shown to release 
profibrotic factors that activate extracellular matrix (ECM) deposition by fibroblasts, 
thereby affecting diastolic function of the heart.  
